FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: PGS

  • Home
  •  | 
  • Tag Archives: "PGS"

Pivot Completes C$1.64 Million Non-Brokered Private Placement

Pivot Completes C$1.64 Million Non-Brokered Private Placement
VANCOUVER, Oct. 22, 2018 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has closed a non-brokered Private Placement (the "Private Placement") for a total of C$1,641,300 and has also settled C$1,500,000 of outstanding debt with the issuance of common shares and share purchase warrant. Proceeds of the Private Placement will be used for general working capital purposes, capital expenditures and patent costs.
Read more

Pivot Signs Letter of Intent With Pharmaflorx For Supply Of Cannabis Oils And Isolates Minimum of 1,000 KG/Annually For Use In Pivot’s Product Pipeline

Pivot Signs Letter of Intent With Pharmaflorx For Supply Of Cannabis Oils And Isolates Minimum of 1,000 KG/Annually For Use In Pivot’s Product Pipeline
Pivot will purchase a minimum of 1,000 kg/year of cannabis oils or isolates from PFX for manufacturing of Pivot's patented portfolio of biocannabis products. Upon receipt of appropriate licenses in Canada, Pivot intends to supply both the Canadian and European Union markets with its suite of patented, formulated and bioavailable products, including CBD and/or THC-based creams, lotions, capsules, tablets, bulk powder, infused beverages and pet supplements, where regulations permit.
Read more